NYSE: NVONovo Nordisk A S Stock Ownership - Who owns Novo Nordisk (Ozempic)?
Insider buying vs selling
Have Novo Nordisk A S insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NVO insiders and whales buy or sell their stock.
NVO Shareholders
What type of owners hold Novo Nordisk A S stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Loomis Sayles Co L P | 0.38% | 17,135,384 | $849.40M | Institution |
| Franklin Resources Inc | 0.33% | 14,702,508 | $728.80M | Institution |
| Morgan Stanley | 0.29% | 12,842,089 | $636.58M | Institution |
| Capital International Investors | 0.25% | 11,211,106 | $555.73M | Institution |
| Goldman Sachs Group Inc | 0.25% | 10,986,778 | $544.61M | Institution |
| Folketrygdfondet | 0.23% | 10,164,137 | $503.84M | Institution |
| Fisher Asset Management LLC | 0.22% | 9,784,222 | $485.00M | Institution |
| Everett Harris Co | 0.14% | 6,407,366 | $317.61M | Institution |
| State Farm Mutual Automobile Insurance Co | 0.14% | 6,142,778 | $304.50M | Institution |
| State Street Corp | 0.13% | 5,996,113 | $297.23M | Institution |
NVO vs Biotech Stocks
Novo Nordisk (Ozempic) Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.